1. |
1 Suerbaum S, Michetti P. Helicobacter pylori infection.
N Engl J Med , 2002, 347(476): 1175-1186.
|
2. |
Lam SK, Talley NJ. Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. Gastroenterol Hepatol , 1998, 13(1): 1-12.
|
3. |
Gisbert JP, Gonzalez L, Calvet X, et al . Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: ameta-analysis of eradication of Helicobacter pylori. Aliment Pharmacol Ther , 2000, 14(10): 1319-1328.
|
4. |
Gisbert JP, Pajares JM. Helicobacter pylori”rescue”regimen when proton pump inhibitor-based triple therapies fail. Aliment Pharmacol Ther , 2002, 16(6): 1047–1057.
|
5. |
Malfertheiner P, Megraud F, O’Morain C, et al . Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut , 2007, 56(6): 772-781.
|
6. |
Malfertheiner P, Megraud F, O’Morain C, et al . Current concepts in the management of Helicobacter pylori infection–the Maastricht 2–2000 Consensus Report. Aliment Pharmacol Ther , 2002, 16(2): 167-180.
|
7. |
Rokkas T, Sechopoulos P, Robotis I, et al . Cumulative HP Eradication Rates in Clinical Practice by Adopting First and Second-Line Regimens Proposed by the Maastricht III Consensus and a Third-Line Empirical Regimen. Am J Gastroenterol , 2009, 104(1): 21-25.
|
8. |
Tong JL, Ran ZH, Shen J, et al . Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis. Journal of Clinical Pharmacy and Therapeutics , 2009, 34(1): 41-53.
|
9. |
Baena JM, Lopez C, Hidalgo A, et al . Relation between alcohol consumption and the success of Helicobacter pylori eradication therapy using comprazole, clarithromycin and amoxicilline for one week. European Journal of Gastroenterology & Hepa-tology , 2002, 14(3): 291-296.
|
10. |
Broutet N, Tchamgoue S, Pereira E, et al . Risk factors for failure of Helicobacter pylori therapy–results of an individual data analysis of 2751patients. Aliment Pharmacol Ther , 2003, 17(1): 99-109.
|
11. |
Namiot Z, Namiot DB, Kemona A, et al . The effect of cigarette smoking and alcohol consumption on efficacy of Helicobacter pylori eradication. Pol Arch Med Wewn , 2000, 104(3): 569-574.
|
12. |
Silva FM, Zaterka S, Eisig JN, et al . Factors affecting Helicobacter pylori eradication using a seven-day triple therapy with a proton pump inhibitor,tinidazole and clarithromycin,in Brazilian patients with peptic ulcer. Rev Hosp Clin Fac Med Sao Paulo , 2001, 56(1): 11-16.
|
13. |
Koivisto TT, Rautelin HI, Voutilainen ME, et al . First-line eradication therapy for Helicobacter pylori in primary health care based on antibiotic resistance:results of three eradication regimens. Aliment Pharmacol Ther , 2005, 21(6): 773-782.
|
14. |
Fischbach L, Evans EL. Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori. Aliment Pharmacol Ther , 2007, 26(3): 343-357.
|
15. |
Wheeldon TU, Granstrom M, Hoang TT, et al . The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication. Aliment Pharmacol Ther , 2004, 19(12): 1315-1321.
|
16. |
Shirai N, Sugimoto M, Kodaira C, et al . Dual therapy with high doses of rabeprazole and amoxicillin versus triple therapy with rabeprazole,amoxicillin,and metronidazole as a rescue regimen for Helicobacter pylori infection after the standard triple therapy. Eur J Clin Pharmacol , 2007, 63(8): 743-749.
|
17. |
Nagahara A, Miwa H, Ohkura R, et al . Strategy for retreatment of therapeutic failure of eradication of Helicobacter pylori infection. J Gastroenterol Hepatol , 2001, 16(6): 613-618.
|
18. |
Gisbert JP, Gisbert JL, Marcos S, et al . Seven-day ”rescue” therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole. Aliment Pharmacol Ther , 1999, 13(10): 1311-1316.
|
19. |
Ferri F, Festa V, Merla A, et al . Randomized study of different ‘second-line’ therapies for Helicobacter pylori infection after failure of the standard Maastricht triple therapy. Aliment Pharmacol Ther , 2003, 18(8): 815-820.
|
20. |
Rinaldi V, Zullo A, De Francesco V, et al . Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy. Aliment Pharmacol Ther , 1999, 13(2): 163-168.
|
21. |
Zullo A, Hassan C, Campo SM, et al . A triple therapy regimen after failed Helicobacter pylori treatments. Aliment Pharmacol Ther , 2001, 15(8): 1193-1197.
|
22. |
Wong MW, Gu Q, Lam SK, et al . Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infection. Aliment Pharmacol Ther , 2003, 17(4): 553-560.
|
23. |
Isakov V, Domareva I, Koudryavtseva L, et al . Furazolidone-based triple ”rescue therapy” vs. quadruple ” rescueTherapy” for the eradication of Helicobacter pylori resistant to metronidazole. Aliment Pharmacol Ther , 2002, 16(7): 1277-1282.
|
24. |
Miehlke S, Hansky K, Schneider-Brachert W, et al . Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin. Aliment Pharmacol Ther , 2006, 24(2): 395-403.
|
25. |
Chao HK, Huang MH, Kuo FC, et al . Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial. J Antimicrol Chemo , 2009, 63(5): 1017-1024.
|
26. |
Gisbert JP, DE LA, Morena F. Systematic review and meta-analysis:levofloxacin-based rescue regimens after Helicobacter pylori treatment failure. Aliment Pharmacol Ther , 2006, 23(8): 1283-1285.
|
27. |
Chi HC, Lin YC, Sheu BS, et al . Quadruple therapy containing amoxicillin and tetracycline is an effective regimen to rescue failed triple therapy by overcoming the antimicrobial resistance of Helicobacter pylori. Aliment Pharmacol Ther , 2003, 18(3): 347-353.
|
28. |
Farup PG, Tholfsen J, Wetternus S, et al . Comparison of three triple regimens with omeprazole or ranitidine bismuth citrate for Helicobacter pylori eradication. Scand J Gastroenterol , 2002, 37(12): 1374-1379.
|
29. |
Gisbert JP, Boixeda D, Bermejo F, et al . Re-treatment after Helicobacter pylori eradication failure. Eur J Gastroenterol Hepatol , 1999, 11(9): 1049-1054.
|
30. |
Calvet X, Ducons J, Guardiola J, et al . One-week triple vs.quadruple therapy for Helicobacter pylori infection–arandomized trial. Aliment Pharmacol Ther , 2002, 16(7): 1261-1267.
|
31. |
Katelaris PH, Forbes GM, Talley NJ, et al . A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE Study. Gastroenterology , 2002, 123(6): 1763-1769.
|
32. |
Fischbach LA, Van Zanten SV, Dickason J, et al . Meta-analysis:the efficacy,adverse events,and adherence related to first-line anti-Helicobacter pylori quadruple therapies. Aliment Pharmacol Ther , 2004, 20(10): 1071-1082.
|
33. |
Phillips PH, Whitehead MW, Doig LA, et al . Is eradication of Helicobacter pylori with colloidal bismuth subcitrate quadruple therapy safe?. Helicobacter , 2001, 6(2): 151-156.
|
34. |
Hung K, Wong M. One-week ranitidine bismuth citrate,amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese. Aliment Pharmacol Ther , 2002, 16(12): 2067-2072.
|
35. |
Alarcon T, Domingo D, Lopez-Brea M. Antibiotic resistance problems with Helicobacter pylori. Int J Antimicrob Agents , 1999, 12(1): 19-26.
|
36. |
Peitz U, Hackelsberger A, Malfertheiner PA. Practical approach to patients with refractory Helicobacter pylori infection, or who are re-infected after standard therapy. Drugs , 1999, 57(6): 905-920.
|
37. |
Deltenre M, Ntounda R, Jonas C, et al . Eradication of Helicobacter pylori: why does it fail?. Ital J Gastroenterol Hepatol , 1998, 30(Suppl.3): S326-328.
|
38. |
Gomollón F, Valdeperez J. Cost-effectiveness analysis of 2 strategies of Helicobacter pylori eradication: results of a prospective and randomized study in primary care. Med Clin , 2000, 115(1): 1-6.
|
39. |
Huang JQ, Hunt RH. Treatment after failure: the problem of ’non-responders’. Gut , 1999, 45(Suppl. 1): 140-144.
|
40. |
Graham DY, Lew GM, Malaty HM, et al . Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology , 1992, 102(2): 493-496.
|
41. |
Wermeille J, Dederding JP, Cunningham M, et al . Failure of Helicobacter pylori eradication in an ambulatory population:Is poor compliance the main cause?. Digestion , 1998, 59(Suppl.3): 437.
|
42. |
Battaglia G, Di Mario F, Vigneri S, et al . Strategy for the retreatment of failed Helicobacter pylori eradication therapy:a case series. Ital J Gastroenterol Hepatol , 1998, 30(4): 370-374.
|